In addition to the dysregulation of mitochondrial quality control, the enhanced DNA damage observed in p53-mutated RCC cells likely reflects their compromised ability to activate canonical p53-dependent DNA damage response and repair pathways. This evidence concerns the gene TP53 and renal cell adenocarcinoma.